Heart health monitoring during chemotherapy
Part of Blood & lymphatic, Cancer clinical trials.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with cancer (solid tumor or blood cancer)
- You are scheduled to receive anthracycline chemotherapy, or have already started and are about to begin your second cycle
- You are able to give written consent to participate
- Your doctor expects you to live more than one year and complete your planned chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses heart imaging scans and blood tests to check if a common cancer drug (anthracycline) is affecting your heart during treatment. Early detection might help doctors protect your heart health.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
This study checks how a common chemotherapy drug (anthracycline) affects the heart in children. It will monitor heart function during treatment to help protect young patients.
This study tracks the heart health of adults receiving chemotherapy that may affect the heart. It helps doctors understand how to better monitor and protect patients.
This study tests whether a supervised exercise program can help keep your heart strong and improve your fitness while you are receiving chemotherapy with drugs called anthracyclines. Participating may help you feel better and reduce some side effects on your heart.
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
Hear when a new Anthracycline-induced Cardiotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.